DNA Damage Enhances Integration of HIV-1 into Macrophages by Overcoming Integrase Inhibition

Overview

Journal Retrovirology

Publisher Biomed Central

Specialty Microbiology

Date 2013 Feb 26

PMID 23432899

Citations 19

Authors

Takayoshi Koyama

Binlian Sun

Kenzo Tokunaga

Masashi Tatsumi

Yukihito Ishizaka

Affiliations

Soon will be listed here.

Abstract

Background: The prevention of persistent human immunodeficiency virus type 1 (HIV-1) infection requires the clarification of the mode of viral transduction into resting macrophages. Recently, DNA double-strand breaks (DSBs) were shown to enhance infection by D64A virus, which has a defective integrase catalytic activity (IN-CA). However, the mechanism by which DSBs upregulate viral transduction was unclear. Here we analyzed the roles of DSBs during IN-CA-independent viral transduction into macrophages.

Results: We used cellular systems with rare-cutting endonucleases and found that D64A virus integrated efficiently into the sites of artificially induced DSBs. This IN-CA-independent viral transduction was blocked by an inhibitor of ataxia telangiectasia mutated protein (ATM) but was resistant to raltegravir (RAL), an inhibitor of integrase activity during strand transfer. Moreover, Vpr, an accessory gene product of HIV-1, induced DSBs in resting macrophages and significantly enhanced the rate of IN-CA-independent viral transduction into macrophages with concomitant production of secondary viruses.

Conclusion: DSBs contribute to the IN-CA-independent viral infection of macrophages, which is resistant to RAL. Thus, the ATM-dependent cellular pathway and Vpr-induced DNA damage are novel targets for preventing persistent HIV-1 infection.

Citing Articles

Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells.

Gomez-Moreno A, San Sebastian E, Moya J, Gomollon-Zueco P, Isola S, Vales A Pharmaceutics. 2023; 15(10).

PMID: 37896219 PMC: 10610421. DOI: 10.3390/pharmaceutics15102459.

Lentiviral Vectors for Ocular Gene Therapy.

Arsenijevic Y, Berger A, Udry F, Kostic C Pharmaceutics. 2022; 14(8).

PMID: 36015231 PMC: 9414879. DOI: 10.3390/pharmaceutics14081605.

Identification of an integrase-independent pathway of retrotransposition.

Li F, Lee M, Esnault C, Wendover K, Guo Y, Atkins P Sci Adv. 2022; 8(26):eabm9390.

PMID: 35767609 PMC: 11042837. DOI: 10.1126/sciadv.abm9390.

Borna disease virus docks on neuronal DNA double-strand breaks to replicate and dampens neuronal activity.

Marty F, Bettamin L, Thouard A, Bourgade K, Allart S, Larrieu G iScience. 2022; 25(1):103621.

PMID: 35024577 PMC: 8724971. DOI: 10.1016/j.isci.2021.103621.

Viral Modulation of the DNA Damage Response and Innate Immunity: Two Sides of the Same Coin.

Lopez A, Nichols Doyle R, Sandoval C, Nisson K, Yang V, Fregoso O J Mol Biol. 2021; 434(6):167327.

PMID: 34695379 PMC: 9119581. DOI: 10.1016/j.jmb.2021.167327.

References

Daniel R, KATZ R, Merkel G, Hittle J, Yen T, Skalka A . Wortmannin potentiates integrase-mediated killing of lymphocytes and reduces the efficiency of stable transduction by retroviruses. Mol Cell Biol. 2001; 21(4):1164-72. PMC: 99570. DOI: 10.1128/MCB.21.4.1164-1172.2001. View

Serrao E, Odde S, Ramkumar K, Neamati N . Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors. Retrovirology. 2009; 6:25. PMC: 2660292. DOI: 10.1186/1742-4690-6-25. View

Mouscadet J, Delelis O, Marcelin A, Tchertanov L . Resistance to HIV-1 integrase inhibitors: A structural perspective. Drug Resist Updat. 2010; 13(4-5):139-50. DOI: 10.1016/j.drup.2010.05.001. View

Nakai-Murakami C, Minemoto Y, Ishizaka Y . Vpr-induced DNA double-strand breaks: molecular mechanism and biological relevance. Curr HIV Res. 2009; 7(2):109-13. DOI: 10.2174/157016209787581391. View

Sakurai Y, Komatsu K, Agematsu K, Matsuoka M . DNA double strand break repair enzymes function at multiple steps in retroviral infection. Retrovirology. 2009; 6:114. PMC: 2797772. DOI: 10.1186/1742-4690-6-114. View

Engelman A, Mizuuchi K, Craigie R . HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell. 1991; 67(6):1211-21. DOI: 10.1016/0092-8674(91)90297-c. View

Engelman A, Englund G, Orenstein J, Martin M, Craigie R . Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol. 1995; 69(5):2729-36. PMC: 188965. DOI: 10.1128/JVI.69.5.2729-2736.1995. View

Wu Y, Marsh J . Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science. 2001; 293(5534):1503-6. DOI: 10.1126/science.1061548. View

Iwabu Y, Kinomoto M, Tatsumi M, Fujita H, Shimura M, Tanaka Y . Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes. J Biol Chem. 2010; 285(46):35350-8. PMC: 2975159. DOI: 10.1074/jbc.M110.173286. View

10.

Daniel R, Marusich E, Argyris E, Zhao R, Skalka A, Pomerantz R . Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells. J Virol. 2005; 79(4):2058-65. PMC: 546572. DOI: 10.1128/JVI.79.4.2058-2065.2005. View

11.

Yamamoto N, Tanaka C, Wu Y, Chang M, Inagaki Y, Saito Y . Analysis of human immunodeficiency virus type 1 integration by using a specific, sensitive and quantitative assay based on real-time polymerase chain reaction. Virus Genes. 2006; 32(1):105-13. DOI: 10.1007/s11262-005-5851-2. View

12.

BRIN E, Yi J, Skalka A, Leis J . Modeling the late steps in HIV-1 retroviral integrase-catalyzed DNA integration. J Biol Chem. 2000; 275(50):39287-95. DOI: 10.1074/jbc.M006929200. View

13.

Baekelandt V, Claeys A, Cherepanov P, De Clercq E, De Strooper B, Nuttin B . DNA-Dependent protein kinase is not required for efficient lentivirus integration. J Virol. 2000; 74(23):11278-85. PMC: 113232. DOI: 10.1128/jvi.74.23.11278-11285.2000. View

14.

Malim M, Emerman M . HIV-1 accessory proteins--ensuring viral survival in a hostile environment. Cell Host Microbe. 2008; 3(6):388-98. DOI: 10.1016/j.chom.2008.04.008. View

15.

Daniel R, KATZ R, Skalka A . A role for DNA-PK in retroviral DNA integration. Science. 1999; 284(5414):644-7. DOI: 10.1126/science.284.5414.644. View

16.

Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T . Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 1982; 42(4):1530-6. View

17.

Nakai-Murakami C, Shimura M, Kinomoto M, Takizawa Y, Tokunaga K, Taguchi T . HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination. Oncogene. 2006; 26(4):477-86. DOI: 10.1038/sj.onc.1209831. View

18.

Anglana M, Bacchetti S . Construction of a recombinant adenovirus for efficient delivery of the I-SceI yeast endonuclease to human cells and its application in the in vivo cleavage of chromosomes to expose new potential telomeres. Nucleic Acids Res. 1999; 27(21):4276-81. PMC: 148704. DOI: 10.1093/nar/27.21.4276. View

19.

DeHart J, Andersen J, Zimmerman E, Ardon O, An D, Blackett J . The ataxia telangiectasia-mutated and Rad3-related protein is dispensable for retroviral integration. J Virol. 2005; 79(3):1389-96. PMC: 544104. DOI: 10.1128/JVI.79.3.1389-1396.2005. View

20.

Jager S, Cimermancic P, Gulbahce N, Johnson J, McGovern K, Clarke S . Global landscape of HIV-human protein complexes. Nature. 2011; 481(7381):365-70. PMC: 3310911. DOI: 10.1038/nature10719. View